Skip to content
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — Marts 2024

Genmab — Marts 2024

Planlagt Fastgjort Låst Flyttet Genmab
830 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • L Offline
    L Offline
    lahn1
    wrote on sidst redigeret af
    #121

    Nej jeg oplever da netop at der er plads til både for og imod, når det er velbegrundet. Kan godt selv logge ud hvis der kommer for mange synsninger af den negative slags.

    1 Reply Last reply
    0
    • JørgenVarnæsJ Offline
      JørgenVarnæsJ Offline
      JørgenVarnæs
      wrote on sidst redigeret af
      #122

      Du kaldte mig en trold

      1 Reply Last reply
      0
      • L Offline
        L Offline
        lahn1
        wrote on sidst redigeret af
        #123

        JKY jeg er enig, men tør næsten ikke tanke om hvad der ville ske hvis Jan blev skiftet ud inden HexCD38 er afklaret. Måske han bare skal være lidt mere PÅ overfor aktionærene

        1 Reply Last reply
        0
        • L Offline
          L Offline
          lahn1
          wrote on sidst redigeret af
          #124

          Forvekslede dig måske med troldmanden 😉

          1 Reply Last reply
          0
          • J Offline
            J Offline
            JKY_VH
            wrote on sidst redigeret af
            #125

            lahn1, hvis jeg skal komme med et frisk bud så vil aktien falde 8-10% i tossetimen på den nyhed og så vil jeg personligt supplere, hvis jeg har mulighed for det;-)

            1 Reply Last reply
            0
            • K Offline
              K Offline
              Klarussen
              wrote on sidst redigeret af
              #126

              Frisk TA-opdatering fra Investtech: https://www.investtech.com/dk/market.php?CompanyID=45104599&tck=genmab

              1 Reply Last reply
              0
              • JørgenVarnæsJ Offline
                JørgenVarnæsJ Offline
                JørgenVarnæs
                wrote on sidst redigeret af
                #127

                Hvorfor skulle aktien falde? Altså ud over den omkostning, der vil være forbundet med at købe JvdW ud?

                1 Reply Last reply
                0
                • J Offline
                  J Offline
                  JKY_VH
                  wrote on sidst redigeret af
                  #128

                  Nå ja, det er jo set før i verdenshistorien at aktier falder når en respekteret CEO træder tilbage.

                  1 Reply Last reply
                  0
                  • L Offline
                    L Offline
                    lahn1
                    wrote on sidst redigeret af
                    #129

                    Tror ikke vi er der, hvor det generelle markede vil se en udskiftning af Jan som en positiv nyhed. Under alle omstændigheder vil det skabe ydereligere usikkerhed.

                    1 Reply Last reply
                    0
                    • E Offline
                      E Offline
                      E_L
                      wrote on sidst redigeret af
                      #130

                      Epcoritamab, a Promising Therapy for Richter Syndrome? https://www.hematologyandoncology.net/archives/march-2024/epcoritamab-a-promising-therapy-for-richter-syndrome/

                      1 Reply Last reply
                      0
                      • E Offline
                        E Offline
                        E_L
                        wrote on sidst redigeret af
                        #131

                        AACR Annual Meeting 2024 Abstract titles via
                        https://www.abstractsonline.com/pp8/#!/20272/presentations/epcoritamab/1

                        1 Reply Last reply
                        0
                        • E Offline
                          E Offline
                          E_L
                          wrote on sidst redigeret af
                          #132

                          the Inclacumab trial still going and seems fully recruited. Primary Completion this summer. I had a very low probability on this
                          , but who knows... https://classic.clinicaltrials.gov/ct2/history/NCT04935879?B=11&A=10&C=merged#StudyPageTop

                          1 Reply Last reply
                          0
                          • E Offline
                            E Offline
                            E_L
                            wrote on sidst redigeret af
                            #133

                            HC Wainwright restated a "buy" rating and issued a $50.00 price target on shares of Genmab A/S in a report on Wednesday.

                            1 Reply Last reply
                            0
                            • E Offline
                              E Offline
                              E_L
                              wrote on sidst redigeret af
                              #134

                              Johnson & Johnson submits application to the European Medicines Agency for DARZALEX® (daratumumab)-based quadruplet therapy for the treatment of patients with transplant-eligible, newly diagnosed multiple myeloma / PERSEUS https://www.globenewswire.com/news-release/2024/03/06/2841454/0/en/Johnson-Johnson-submits-application-to-the-European-Medicines-Agency-for-DARZALEX-daratumumab-based-quadruplet-therapy-for-the-treatment-of-patients-with-transplant-eligible-newly-.html

                              1 Reply Last reply
                              0
                              • E Offline
                                E Offline
                                E_L
                                wrote on sidst redigeret af
                                #135

                                Daratumumab in Pediatric Heart Transplantation. https://twitter.com/PHTSociety/status/1765385728102404100/photo/1

                                1 Reply Last reply
                                0
                                • L Offline
                                  L Offline
                                  lahn1
                                  wrote on sidst redigeret af
                                  #136

                                  Tak EL !

                                  1 Reply Last reply
                                  0
                                  • troldmandenT Offline
                                    troldmandenT Offline
                                    troldmanden
                                    wrote on sidst redigeret af
                                    #137

                                    Novo har lige fremhævet Mim8. At det er en prioritet at maximize Mim8 muligheden

                                    1 Reply Last reply
                                    0
                                    • R Offline
                                      R Offline
                                      Riis7
                                      wrote on sidst redigeret af
                                      #138

                                      Genmab skal ha det Novo tager;-)

                                      1 Reply Last reply
                                      0
                                      • E Offline
                                        E Offline
                                        E_L
                                        wrote on sidst redigeret af
                                        #139

                                        https://www.morningstar.com/company-reports/1211878-genmab-strong-royalty-revenue-from-darzalex-provides-ample-cash-flow-shares-undervalued?listing=0P0000A5QU morningstar maintains fair value target of 2650

                                        1 Reply Last reply
                                        0
                                        • P Offline
                                          P Offline
                                          peter12
                                          wrote on sidst redigeret af
                                          #140

                                          Nu skal der sælges epo https://www.roi-nj.com/2024/03/07/healthcare/genmab-promising-to-add-300-jobs-to-2nd-location-in-plainsboro-gets-8-4m-emerge-tax-credit/

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper